<bill session="115" type="h" number="934" updated="2017-06-19T21:00:23Z">
  <state datetime="2017-02-07">REFERRED</state>
  <status>
    <introduced datetime="2017-02-07"/>
  </status>
  <introduced datetime="2017-02-07"/>
  <titles>
    <title type="short" as="introduced">Personal Drug Importation Fairness Act of 2017</title>
    <title type="short" as="introduced">Personal Drug Importation Fairness Act of 2017</title>
    <title type="official" as="introduced">To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.</title>
    <title type="display">Personal Drug Importation Fairness Act of 2017</title>
  </titles>
  <sponsor bioguide_id="E000288"/>
  <cosponsors>
    <cosponsor bioguide_id="R000409" joined="2017-02-07"/>
  </cosponsors>
  <actions>
    <action datetime="2017-02-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-02-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-02-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Africa"/>
    <term name="Asia"/>
    <term name="Australia"/>
    <term name="Canada"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Israel"/>
    <term name="Japan"/>
    <term name="New Zealand"/>
    <term name="Oceania"/>
    <term name="Prescription drugs"/>
    <term name="South Africa"/>
    <term name="Switzerland"/>
    <term name="Trade restrictions"/>
  </subjects>
  <amendments/>
  <summary date="2017-02-07T05:00:00Z" status="Introduced in House">Personal Drug Importation Fairness Act of 2017

This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.</summary>
  <committee-reports/>
</bill>
